Tagged Articles

profits 47 articles

Second Actos bladder-cancer lawsuit goes to trial

Drug maker Takeda Pharmaceuticals cared more about profits than human safety when it failed to warn consumers that its blockbuster type 2 diabetes drug Actos put users at risk for bladder cancer, argued a plaintiff’s attorney in the second Actos bladder cancer lawsuit to go to trial. The lawsuit was filed by the family of Diep An, who was diagnosed with “high grade bladder cancer” in September 2011, after taking Actos for four years. An died four months after his diagnosis. Attorneys for An’s family argued that Takeda, Asia’s biggest drug maker, knew as early as 2005 that studies had ... Read More

FDA panelists conflicted on approval of long-lasting testosterone injection

A U.S. Food & Drug Administration (FDA) panel was split on its opinion about the safety of a long-lasting testosterone injection submitted for approval, with nine members backing the drug and nine saying that it’s still too risky to put on the market. Endo Health Solutions, which first submitted its drug AVEED (testosterone undecanoate) for FDA approval in 2007, designed the drug to be in injected once every 10 weeks for the treatment of abnormally low testosterone caused by damage to the reproductive system or hormonal organs from disease or injury. Low testosterone, or hypogonadism, can cause muscle loss, lack ... Read More

Bayer’s profits take a hit due to Yaz lawsuits

Lawsuits against the birth control pill Yaz took a huge bite out of Bayer’s fourth quarter profits. The company reported net profits of $490 million, a far cry from the $519 million it brought in last year. The company cited charges due to Yaz lawsuits in the United States as the culprit for lagging profits. The lawsuits claim that Yaz causes blood clots that can lead to sometimes fatal heart attacks, strokes and pulmonary embolisms. Yaz is Bayer’s once mega-popular birth control pill. It contains the hormones drospirenone and ethinyl estradiol. While all combination oral contraceptives can increase a woman’s ... Read More

Charlie Sheen blames crazy behavior on testosterone drugs

Charlie Sheen will probably spend the rest of his life trying to explain his public meltdown in 2011 after a night of drugs, porn stars, and rage landed him in the hospital. In interviews about that infamous night and other personal and professional troubles, Mr. Sheen has claimed he is a “warlock” with “tiger’s blood” and a “total bitchin’ rock star from Mars” whose brain “fires in a way that’s maybe not from this terrestrial realm.” But in a recent interview, Mr. Sheen claimed to know the real reason behind his psychotic behavior: testosterone cream. “Were you under the influence ... Read More

Abbott’s new testosterone test gets FDA clearance

The U.S. Food and Drug Administration (FDA) has approved a new method of analyzing testosterone levels in men and women. The new chemical analysis is made by Abbott Laboratories, the drug maker whose sales of Androgel testosterone-replacement gel achieved blockbuster status in recent months, earning the company nearly $900 million in 2011. According to Abbott, its new testosterone assay should help doctors more accurately measure testosterone levels, which vary widely in both men and women. Abbot reported on its website that published studies have demonstrated that many testosterone tests currently used are not sufficiently sensitive to accurately measure low testosterone ... Read More

Only two percent of men should receive synthetic testosterone, researcher say

Testosterone levels in men often diminish with age, leading to a decrease in muscle mass and strength that can leave men frail and less mobile. Other side effects of low testosterone levels, or “low T” as the condition is called by drug marketers, can include diminished energy and sex drive. To restore their overall vitality, aging men and others just seeking a hormonal boost for recreational purposes are turning to synthetic testosterone replacement drugs in record numbers. Abbott Laboratories, which produces the topical hormone drug AndroGel, and Auxilium Pharmaceuticals, the maker of a similar drug called Testim, are all too ... Read More

Analyst: diabetes drug sales expected to more than double by 2020

Sales of diabetes drugs should keep growing at about 10 percent a year for the rest of the decade, reaching $65 billion a year by 2020, says Jeffrey Holford, an analyst with Jefferies & Co. At that pace, diabetes drug revenues should more than double from the current $30 billion by the decade’s end. Holford says diabetes drug revenues should rise in relation to the aging population in the West, while in emerging markets, diabetes and obesity are increasing and access to health care is also growing. Other factors considered include higher drug prices, strong patent protection for key drugs, ... Read More

Obese teen boys have radically low testosterone levels, study finds

It’s no mystery that obese teenage boys are at a heightened risk of developing diabetes and heart disease, but a new study published last week in the journal Clinical Endocrinology found that obese boys have alarmingly low testosterone levels as well – between 40 to 50 percent less than males of the same age with a normal body mass index (BMI). The study, conducted by researchers at the University of Buffalo, builds on earlier research the same scientists completed in 2004, which discovered low testosterone levels (hypogonadism) in older obese males ages 18 to 35, both diabetic and non-diabetic. Dr. ... Read More

Maryland man receives 5-year sentence for illegally distributing AndroGel

A Hagerstown, Maryland, man was sentenced to serve 366 days in a state prison Thursday after he pleaded guilty to illegally distributing AndroGel, a topical testosterone replacement drug made by Abbott Laboratories. According to the Herald-Mail, a Circuit Court Judge sentenced Timothy Allen Feigley, 33, to five years in state prison – the maximum sentence for distributing a Schedule III controlled dangerous substance, but suspended all but one year and one day. Mr.  Feigey also received credit for 139 days he already served. Additionally, Mr. Feigley will be put on probation or three years upon his release. The state dismissed ... Read More

Lawsuits against transvaginal mesh manufacturers impact stock values

Lawsuits against manufacturers of transvaginal mesh devices are adversely affecting companies’ stock prices, according to Trefis: What’s Driving the Stock. The analyst points to the “continuous surge” of product liability lawsuits waged against companies such as Johnson & Johnson and Boston Scientific. ‘’While these litigation costs and settlements may have an immediate impact on the cash reserves, one should be concerned about its long-term impact on business, which could be hard to assess.” Transvaginal mesh is a surgical mesh device used to treat pelvic floor disorders in women such as pelvic organ prolapse and stress urinary incontinence. The devices are ... Read More